More than 800 people are expected to converge on Orlando, Florida, in late October for the 35th National Convention of the Prader-Willi Syndrome Association (PWSA). The event, to take place over a four-day period at the Caribe Royale Hotel, is divided into three segments: a two-day medical and scientific…
News
Saniona announced that adolescents with Prader-Willi syndrome (PWS) showed improvements in weight, body mass index (BMI), and hyperphagia score — measuring appetite reduction — when treated with the investigational therapy…
The deficit in social cognitive abilities among young children with Prader-Willi syndrome (PWS) starts at an early age — and varies with the genetic subtype, a study found. Children with PWS who inherit two chromosomes 15 from their mother showed manifestations similar to those of autism spectrum…
Newborns with Prader-Willi syndrome often have a lower birth weight and can be shorter than newborns who do not have this rare disease, a study conducted in Italy reports. Recognition of these body features may help clinicians in diagnosing the syndrome earlier, and in beginning suitable support and treatment measures…
Rare diseases deeply affect not only the children who experience them, but also their healthy brothers and sisters, as their parents can attest. Two entries in November’s “Disorder: The Rare Disease Film Festival” will focus on what siblings go through, according to the San Francisco festival’s co-founder,…
Both growth friendly surgery (GFS) and serial cast correction (SCC) were found to help resolve early-onset scoliosis, and to improve spine structure, in children with Prader-Willi syndrome (PWS), according to a two-year study. The findings from the study, “Growth Friendly Surgery and Serial Cast…
Developing gene therapies for rare diseases is one thing. Creating gene-edited “designer babies” is quite another. German legal expert Timo Minssen outlined the potentially explosive ethical landmines surrounding such issues during a recent talk at the New York Genome Center. Minssen directs the Center for Advanced Studies in…
Saniona will continue to develop Tesomet (tesofensine/metoprolol) as a potential therapy for Prader-Willi syndrome (PWS), with results from a Phase 2a clinical study expected to be reported soon. The company has completed a rights issue in which it sold some of Saniona’s shares, resulting in gross revenue of SEK…
The upcoming Research Symposium and Family Conference, hosted by the Foundation for Prader-Willi Research (FPWR), will offer the latest in research studies and promising treatments, and the opportunity to connect with the Prader-Willi syndrome (PWS) community. Held in conjunction with the PWS Research Symposium, the annual event will…
People with Prader–Willi syndrome (PWS) who received growth hormone therapy had significantly higher vocabulary IQ scores compared with those who did not have the treatment, a study shows. The study also revealed that PWS patients whose disease is caused by maternal…
Recent Posts
- PWS patients see weight loss, less hunger with setmelanotide in trial
- Eye-tracking test adapted to better measure hunger behaviors in PWS
- We struggled to find mental health support for our son with PWS
- How Prader-Willi families can enjoy the holiday season
- Diabetes medications may support kidney health in adults with PWS
- How parenting and caregiving have changed since we began
- Siblings of PWS patients require tailored support as they grow up
- Can BMB-105 ease insatiable hunger? PWS program to find out.
- My son’s first PWS camping trip was a success
- Lessons I’ve learned on my journey of caregiving